logo
logo

Recode Therapeutics, Inc. announced it raised $1 Million in an amended filing from an offering of $3 Million

Mar 02, 2017•over 8 years ago

Amount Raised

$1 Million

Menlo ParkBiotechnologyHealth Care

Company Information

Company

ReCode Therapeutics

Location

Menlo Park, California, United States

About

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Related People